Fig. 4From: Sustain-release lipid-liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL/6 micein vivo oral LD50 (median lethal dose) of pexiganan for C57BL/6 mice modelBack to article page